Skip Main Links
Important Safety Information
For Healthcare
Providers
Sign Me Up

FIND A DOCTOR

Connect with a healthcare provider

A man discussing his narcolepsy symptoms with a doctor

Reasons to talk to a doctor about
XYWAV today

XYWAV is taken at night and thought to work during sleep to help improve cataplexy and/or excessive daytime sleepiness (EDS) in narcolepsy during the day.*

With only 131 mg of sodium at the equivalent 9‑g nightly dose, XYWAV contains ~1509 mg less sodium per night than all high‑sodium oxybates at the equivalent dose. This means choosing XYWAV over high‑sodium oxybates can help treat your symptoms of cataplexy and/or EDS in narcolepsy, while also reducing your intake over time.

*The exact way XYWAV works for the treatment of cataplexy and EDS in patients with narcolepsy is unknown.

Inclusion of these healthcare providers in this directory does not imply their endorsement, referral, or recommendation of Jazz products. Likewise, inclusion in this directory does not represent an endorsement, referral, or recommendation by Jazz of these healthcare providers. Jazz does not supervise the medical care furnished through these providers. No fees have been exchanged for inclusion in this database. This list may not be complete. This list does not guarantee accuracy. Whom you select as your healthcare provider is your sole responsibility. This decision should be made with great care and in consultation with a trusted healthcare provider. Jazz is not liable to you or others for any decisions made in consideration of the information received from this site.

If you think you might have narcolepsy, don't stop advocating for yourself. Keep doing your research and find a team knowledgeable about the condition.”

Jake

Diagnosed with narcolepsy type 1.

LIVING WITH NARCOLEPSY

Compensated for his time. Results may vary.

Prepare for your next appointment by reflecting on how your symptoms are impacting you.

Up Arrow Icon
Sign Me Up

This site is intended for US residents only.

© 2024 Jazz Pharmaceuticals, Inc. US-XYW-2200245 Rev1025